422 related articles for article (PubMed ID: 10720971)
1. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamics.
Breborowicz A; Polubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Moberly J; Martis L; Oreopoulos D
Perit Dial Int; 2001; 21(2):130-5. PubMed ID: 11330555
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.
Breborowicz A; Polubinska A; Moberly J; Ogle K; Martis L; Oreopoulos D
Am J Kidney Dis; 2001 Mar; 37(3):594-600. PubMed ID: 11228185
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.
Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2001; 17():42-6. PubMed ID: 11510294
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan.
Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1999 Feb; 55(2):667-73. PubMed ID: 9987091
[TBL] [Abstract][Full Text] [Related]
7. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
8. Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients.
Moberly JB; Sorkin M; Kucharski A; Ogle K; Mongoven J; Skoufos L; Lin L; Bailey S; Rodela H; Mupas L; Walele A; Ogrinc F; White D; Wolfson M; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2003; 23(1):63-73. PubMed ID: 12691509
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency.
Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1999; 19 Suppl 2():S106-11. PubMed ID: 10406503
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan and peritoneal ultrafiltration: a test of the "filter-cake" hypothesis.
Rosengren BI; Carlsson O; Rippe B
Am J Kidney Dis; 2001 Jun; 37(6):1277-85. PubMed ID: 11382699
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan preserves peritoneal membrane transport properties.
Guo QY; Peng WX; Cheng HH; Ye RG; Lindholm B; Wang T
Perit Dial Int; 2001; 21(2):136-42. PubMed ID: 11330556
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
13. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
14. N-acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats.
Wu G; Wieczorowska-Tobis K; Polubinska A; Korybalska K; Filas V; Tam P; French I; Breborowicz A
Perit Dial Int; 1998; 18(2):217-24. PubMed ID: 9576372
[TBL] [Abstract][Full Text] [Related]
15. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
16. Effect of hyaluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells.
Breborowicz A; Pyda M; Moberly J; Martis L; Oreopoulos D
Am J Nephrol; 2004; 24(3):316-21. PubMed ID: 15148458
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan reduces colitis-induced intraperitoneal inflammation during peritoneal dialysis.
Tomasz J; Andrzej B
Perit Dial Int; 2022 Mar; 42(2):212-217. PubMed ID: 33998321
[TBL] [Abstract][Full Text] [Related]
18. Chronic peritoneal dialysis in iron-deficient rats with solutions containing iron dextran.
Reddy DK; Moore HL; Lee JH; Saran R; Nolph KD; Khanna R; Twardowski ZJ
Kidney Int; 2001 Feb; 59(2):764-73. PubMed ID: 11168960
[TBL] [Abstract][Full Text] [Related]
19. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation.
Pawlaczyk K; Polubinska A; Numata N; Nakayama M; Pecoits-Filho R; Czekalski S; Lindholm B; Breborowicz A
Int J Artif Organs; 2008 Jun; 31(6):535-44. PubMed ID: 18609506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]